Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 35,014 | 121,466 | 77,335 |
| Marketable Securities | 86,504 | N/A | N/A |
| Other current assets | 0 | 0 | 371 |
| TOTAL | $126,121 | $124,294 | $80,048 |
| Non-Current Assets | |||
| PPE Net | 1,028 | 1,056 | 998 |
| Investments And Advances | 7,012 | 0 | 0 |
| Other Non-Current Assets | 12,781 | 14,457 | 16,030 |
| TOTAL | $20,821 | $15,513 | $17,028 |
| Total Assets | $146,942 | $139,807 | $97,076 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 6,417 | 3,794 | 2,678 |
| Accrued Expenses | 13,759 | 10,840 | 8,331 |
| TOTAL | $22,846 | $17,239 | $14,349 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 6,437 | 7,786 | 194,033 |
| TOTAL | $7,254 | $9,033 | $195,681 |
| Total Liabilities | $30,100 | $26,272 | $210,034 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 33,197 | 26,669 | N/A |
| Common Shares | 3 | 3 | N/A |
| Retained earnings | -280,173 | -181,840 | -115,446 |
| Other shareholders' equity | -120 | 0 | 0 |
| TOTAL | $116,842 | $113,535 | $-112,954 |
| Total Liabilities And Equity | $146,942 | $139,807 | $97,080 |